Literature DB >> 2045622

Androgen receptors in normal and pathological thyroids.

M Marugo1, G Torre, D Bernasconi, L Fazzuoli, S Cassulo, G Giordano.   

Abstract

The purpose of this study was to determine the presence of cytosolic and nuclear androgen receptors (AR) in both normal and nodular thyroid tissues from twelve women and six men. Samples of benign thyroid nodules and corresponding surrounding normal tissue were processed by the single saturation point assay, using [3H] R1881 ([3H] Methyltrienolone) at final concentration of 5 nM. The results show the presence of AR (cytosolic and/or nuclear) in all examined tissue samples. The nuclear AR content was higher (p less than 0.01) in normal rather than in nodular thyroid tissues. The same pattern was observed when nuclear AR were analyzed according to the sex. In addition, nuclear AR content was significantly (p less than 0.05) higher in normal thyroid tissue from men than from women. Our data suggest an androgen influence on thyroid tissue. If androgens are supposed to exert an antagonist role on estrogen actions also in thyroid tissue, the presence of higher nuclear AR concentration in the male rather than in the female normal thyroid may justify the lower incidence of thyroid diseases in men. Moreover, the lower AR levels found in male as well as in female nodular and goitrous tissues support the hypothesis that androgens may act with an antagonist mechanism on thyroid growth.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2045622     DOI: 10.1007/BF03350254

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  19 in total

1.  Androgenization: alterations in the mechansim of oestrogen action.

Authors:  R T Lobl
Journal:  J Endocrinol       Date:  1975-07       Impact factor: 4.286

Review 2.  Thyroid-stimulating hormone: neuroregulation and clinical applications. Part 1.

Authors:  M F Scanlon; B Rees Smith; R Hall
Journal:  Clin Sci Mol Med       Date:  1978-07

Review 3.  Dynamics of steroid hormone receptor action.

Authors:  B S Katzenellenbogen
Journal:  Annu Rev Physiol       Date:  1980       Impact factor: 19.318

4.  Estrogen and thyroid-stimulating hormone (TSH) receptors in neoplastic and nonneoplastic human thyroid tissue.

Authors:  O H Clark; P L Gerend; M Davis; P E Goretzki; P G Hoffman
Journal:  J Surg Res       Date:  1985-02       Impact factor: 2.192

5.  Immunoreactive insulin-like growth factor I (IGF-I) and IGF-I-binding protein content in human thyroid tissue.

Authors:  F Minuto; A Barreca; P Del Monte; G Cariola; G C Torre; G Giordano
Journal:  J Clin Endocrinol Metab       Date:  1989-03       Impact factor: 5.958

6.  Thyroid and steroid receptors.

Authors:  M Marugo; G Torre; D Bernasconi; L Fazzuoli; S Berta; G Giordano
Journal:  J Endocrinol Invest       Date:  1989-09       Impact factor: 4.256

7.  A differential nuclear uptake and retention of 3H-androgens in the thyroids of baboons.

Authors:  P J Sheridan; T B Aufdemorte; R G Triplett; G Holt; P M Martin
Journal:  J Endocrinol Invest       Date:  1988-09       Impact factor: 4.256

8.  Androgen receptors in human thyroid tissue.

Authors:  R A Prinz; L Sandberg; P K Chaudhuri
Journal:  Surgery       Date:  1984-12       Impact factor: 3.982

9.  An antiestrogenic action of androgens in human breast cancer cells.

Authors:  J H MacIndoe; L A Etre
Journal:  J Clin Endocrinol Metab       Date:  1981-10       Impact factor: 5.958

10.  Incidence of thyroid cancer in women in relation to reproductive and hormonal factors.

Authors:  A M McTiernan; N S Weiss; J R Daling
Journal:  Am J Epidemiol       Date:  1984-09       Impact factor: 4.897

View more
  3 in total

1.  Androgen receptor expression in C-cells and in medullary thyroid carcinoma.

Authors:  Qi-Hui Zhai; Katharina Ruebel; Geoffrey B Thompson; Ricardo V Lloyd
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

2.  Metabolic alteration of urinary steroids in pre- and post-menopausal women, and men with papillary thyroid carcinoma.

Authors:  Man Ho Choi; Ju-Yeon Moon; Sung-Hee Cho; Bong Chul Chung; Eun Jig Lee
Journal:  BMC Cancer       Date:  2011-08-08       Impact factor: 4.430

3.  Aberrant Expression of Androgen Receptor Associated with High Cancer Risk and Extrathyroidal Extension in Papillary Thyroid Carcinoma.

Authors:  Chen-Kai Chou; Shun-Yu Chi; Fong-Fu Chou; Shun-Chen Huang; Jia-He Wang; Chueh-Chen Chen; Hong-Yo Kang
Journal:  Cancers (Basel)       Date:  2020-04-29       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.